Researchers at the Yong Loo Lin School of Medicine, National University of Singapore, have pinpointed a protein that could restore the brain’s capacity to generate new cells even in later life. The study, appearing in Science Advances, highlights the transcription factor cyclin D‑binding myb‑like transcription factor 1 (DMTF1) as a key driver of neural stem‑cell activity in older brains.
Why Neural Stem Cells Matter
Neural stem cells are the brain’s internal repair crew, producing fresh neurons that support learning and memory. As we age, these cells gradually lose their vigor, contributing to the slowdown of cognitive functions.
Exploring DMTF1’s Role
The team examined stem cells taken from human donors and from laboratory models that mimic premature aging. By mapping DMTF1’s binding sites and monitoring gene‑expression changes, they discovered that the protein directly influences genes involved in DNA loosening, a prerequisite for cell renewal.
Reviving Aged Stem Cells
Older neural stem cells showed markedly lower levels of DMTF1. When researchers re‑introduced the protein, the cells regained their ability to proliferate and differentiate, suggesting that boosting DMTF1 could rejuvenate the aging brain.
Therapeutic Outlook
These findings point to two possible strategies: increasing DMTF1 expression or designing small molecules that enhance its activity. Such approaches might delay or even reverse the decline in stem‑cell function linked to telomere shortening and natural aging, without raising the risk of tumor formation.
Next Steps
While the current data come from cell‑culture experiments, the researchers plan animal studies to test whether elevating DMTF1 can boost stem‑cell numbers, improve memory performance, and remain safe over the long term. If successful, this line of work could lay the groundwork for new treatments aimed at preserving brain health in older adults.